TOKYO, June 11 (Reuters) - A group of Takeda PharmaceuticalCo Ltd shareholders is building support to block the$62 billion acquisition of London-listed Shire Plc at anextraordinary general meeting, a leading member of the grouptold Reuters on Monday.
The 130 member group formed by ex-Takeda employees hold onepercent of the drugmaker's shares, and needs the support of athird of shareholders.
It is targeting domestic retail investors and overseasinstitutional investors who own 25 percent and 35 percent ofTakeda shares respectively, the person said on condition ofanonymity.
The group includes members of the founding Takeda family,Nikkan Yakugyo reported last month. The family owns about 10percent of Takeda shares, people familiar with the matter toldReuters.
The group's attempt to block the appointment ofthen-Chairman Yasuchika Hasegawa to an advisory position wasdefeated at last year's annual general meeting after gaining30.5 percent of votes.(Reporting by Sam NusseyEditing by Christopher Cushing)